0001437749-21-009955.txt : 20210428
0001437749-21-009955.hdr.sgml : 20210428
20210428083227
ACCESSION NUMBER: 0001437749-21-009955
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20210428
DATE AS OF CHANGE: 20210428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarrabain Alex
CENTRAL INDEX KEY: 0001736937
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21861511
MAIL ADDRESS:
STREET 1: 18908 89 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5T 6B7
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
5
1
rdgdoc.xml
FORM 5
X0306
5
2019-12-31
0
1
0001653821
CEN BIOTECH INC
CENBF
0001736937
Tarrabain Alex
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
1
Chief Financial Officer
Common Stock
2019-01-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-02-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-03-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-04-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-05-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-05-16
4
A
0
L
1250000
0
A
1421942
D
Common Stock
2019-06-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-07-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-08-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-09-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-10-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-11-16
4
J
0
L
3000
0
A
1421942
D
Common Stock
2019-12-16
4
J
0
L
3000
0
A
1421942
D
36,000 shares of common stock of the issuer were issued as consideration for extending the maturity date of a promissory note dated January 14, 2018 and were acquired in increments of 3,000 shares on the following dates: 01/16/2019; 02/16/2019; 03/16/2019; 04/16/2019; 05/16/2019; 06/16/2019; 07/16/2019; 08/16/2019; 09/16/2019; 10/16/2019; 11/16/2019 and 12/16/2019.
Includes 30,000 shares issuable upon conversion of a convertible promissory note held by the reporting person which was issued on October 26, 2016 in the amount of $48,000.
1,250,000 shares of common stock of the issuer were granted by the issuer on May 16, 2019, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
/s/ Alex Tarrabain
2021-04-28